User profiles for Scott Williams

Scott M Williams

- Verified email at case.edu - Cited by 22418

Scott Williams

- Verified email at petermac.org - Cited by 12674

Scott A. Williams

- Verified email at nyu.edu - Cited by 2851

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective …

…, A Matera, A Herschtal, A Iravani, RJ Hicks, S Williams… - The Lancet, 2020 - thelancet.com
Background Conventional imaging using CT and bone scan has insufficient sensitivity
when staging men with high-risk localised prostate cancer. We aimed to investigate whether …

The genetic structure and history of Africans and African Americans

…, MA Thera, C Wambebe, JL Weber, SM Williams - science, 2009 - science.org
Africa is the source of all modern humans, but characterization of genetic variation and of
relationships among populations across the continent has been enigmatic. We studied 121 …

[HTML][HTML] Enzalutamide with standard first-line therapy in metastatic prostate cancer

…, E Tu, F Vera-Badillo, SG Williams… - … England Journal of …, 2019 - Mass Medical Soc
Background Enzalutamide, an androgen-receptor inhibitor, has been associated with improved
overall survival in men with castration-resistant prostate cancer. It is not known whether …

[HTML][HTML] The missing diversity in human genetic studies

G Sirugo, SM Williams, SA Tishkoff - Cell, 2019 - cell.com
The majority of studies of genetic association with disease have been performed in Europeans.
This European bias has important implications for risk prediction of diseases across …

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

…, P Eu, P Jackson, M Scalzo, SG Williams… - The Lancet …, 2018 - thelancet.com
Background Progressive metastatic castration-resistant prostate cancer is a highly lethal
disorder and new effective therapeutic agents that improve patient outcomes are urgently …

Homo naledi, a new species of the genus Homo from the Dinaledi Chamber, South Africa

…, LK Delezene, TL Kivell, HM Garvin, SA Williams… - elife, 2015 - elifesciences.org
10.7554/eLife.09560.001 Homo naledi is a previously-unknown species of extinct hominin
discovered within the Dinaledi Chamber of the Rising Star cave system, Cradle of Humankind…

[177Lu] Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

…, MM McJannett, MR Stockler, JA Violet, SG Williams… - The Lancet, 2021 - thelancet.com
Background Lutetium-177 [ 177 Lu]Lu-PSMA-617 is a radiolabelled small molecule that delivers
β radiation to cells expressing prostate-specific membrane antigen (PSMA), with activity …

Haplotype Diversity and Linkage Disequilibrium at Human G6PD: Recent Origin of Alleles That Confer Malarial Resistance

…, A Tagarelli, G Tagarelli, EH Touma, SM Williams… - Science, 2001 - science.org
The frequencies of low-activity alleles of glucose-6-phosphate dehydrogenase in humans
are highly correlated with the prevalence of malaria. These “deficiency” alleles are thought to …

Bioinformatics challenges for genome-wide association studies

JH Moore, FW Asselbergs, SM Williams - Bioinformatics, 2010 - academic.oup.com
Motivation: The sequencing of the human genome has made it possible to identify an informative
set of >1 million single nucleotide polymorphisms (SNPs) across the genome that can …

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study

…, L Zajdlewicz, N Dunglison, R Carter, S Williams… - The Lancet, 2016 - thelancet.com
Background The absence of trial data comparing robot-assisted laparoscopic prostatectomy
and open radical retropubic prostatectomy is a crucial knowledge gap in uro-oncology. We …